Free Trial

MarketBeat Instant News Alerts

Netskope logo with Services background

Netskope Inc. (NASDAQ:NTSK) Receives Consensus Recommendation of "Buy" from Brokerages

Netskope Inc. (NASDAQ:NTSK - Get Free Report) has been assigned an average rating of "Buy" from the eleven analysts that are presently covering the company, Marketbeat.com reports. Eleven investment analysts have rated the stock with a buy recommendation. The average twelve-month price target amon

NASDAQ:NTSK
Read Netskope Inc. (NASDAQ:NTSK) Receives Consensus Recommendation of "Buy" from Brokerages
Corvus Pharmaceuticals logo with Medical background

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and four have given a

NASDAQ:CRVS
Read Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Recommendation of "Moderate Buy" by Analysts
Glaukos logo with Medical background

Glaukos (NYSE:GKOS) Price Target Lowered to $104.00 at BTIG Research

BTIG Research dropped their price target on shares of Glaukos from $118.00 to $104.00 and set a "buy" rating on the stock in a research report on Monday.

NYSE:GKOS
Read Glaukos (NYSE:GKOS) Price Target Lowered to $104.00 at BTIG Research
Estee Lauder Companies logo with Consumer Staples background

The Goldman Sachs Group Upgrades Estee Lauder Companies (NYSE:EL) to "Buy"

The Goldman Sachs Group raised Estee Lauder Companies from a "neutral" rating to a "buy" rating and raised their target price for the stock from $76.00 to $115.00 in a research report on Monday.

NYSE:EL
Read The Goldman Sachs Group Upgrades Estee Lauder Companies (NYSE:EL) to "Buy"
Zimmer Biomet logo with Medical background

Zimmer Biomet (NYSE:ZBH) Given New $122.00 Price Target at BTIG Research

BTIG Research increased their target price on Zimmer Biomet from $118.00 to $122.00 and gave the company a "buy" rating in a research report on Monday.

NYSE:ZBH
Read Zimmer Biomet (NYSE:ZBH) Given New $122.00 Price Target at BTIG Research
Celldex Therapeutics logo with Medical background

Celldex Therapeutics (NASDAQ:CLDX) Now Covered by Analysts at Barclays

Barclays initiated coverage on shares of Celldex Therapeutics in a research report on Monday. They set an "underweight" rating and a $25.00 target price on the stock.

NASDAQ:CLDX
Read Celldex Therapeutics (NASDAQ:CLDX) Now Covered by Analysts at Barclays

Trending News

All MarketBeat Instant News Alerts

NioCorp Developments logo with Basic Materials background

NioCorp Developments (NASDAQ:NB) Releases Q1 2026 Earnings Guidance

NASDAQ:NB
Read NioCorp Developments (NASDAQ:NB) Releases Q1 2026 Earnings Guidance
Abeona Therapeutics logo with Medical background

Abeona Therapeutics' (ABEO) "Buy" Rating Reiterated at HC Wainwright

NASDAQ:ABEO
Read Abeona Therapeutics' (ABEO) "Buy" Rating Reiterated at HC Wainwright
Advanced Energy Industries logo with Computer and Technology background

Advanced Energy Industries (NASDAQ:AEIS) Price Target Raised to $188.00

NASDAQ:AEIS
Read Advanced Energy Industries (NASDAQ:AEIS) Price Target Raised to $188.00
Baldwin Insurance Group logo with Finance background

Baldwin Insurance Group's (BWIN) Market Perform Rating Reaffirmed at BMO Capital Markets

NASDAQ:BWIN
Read Baldwin Insurance Group's (BWIN) Market Perform Rating Reaffirmed at BMO Capital Markets
eBay logo with Retail/Wholesale background

Robert W. Baird Issues Positive Forecast for eBay (NASDAQ:EBAY) Stock Price

NASDAQ:EBAY
Read Robert W. Baird Issues Positive Forecast for eBay (NASDAQ:EBAY) Stock Price
eToro Group logo with Finance background

eToro Group (NASDAQ:ETOR) Coverage Initiated at Compass Point

NASDAQ:ETOR
Read eToro Group (NASDAQ:ETOR) Coverage Initiated at Compass Point
Gain Therapeutics logo with Medical background

Gain Therapeutics (NASDAQ:GANX) Given "Buy" Rating at HC Wainwright

NASDAQ:GANX
Read Gain Therapeutics (NASDAQ:GANX) Given "Buy" Rating at HC Wainwright
Humacyte logo with Medical background

Humacyte (NASDAQ:HUMA) Price Target Cut to $6.00 by Analysts at BTIG Research

NASDAQ:HUMA
Read Humacyte (NASDAQ:HUMA) Price Target Cut to $6.00 by Analysts at BTIG Research
Intuitive Surgical logo with Medical background

Intuitive Surgical (NASDAQ:ISRG) Given New $529.00 Price Target at BTIG Research

NASDAQ:ISRG
Read Intuitive Surgical (NASDAQ:ISRG) Given New $529.00 Price Target at BTIG Research
MKS logo with Computer and Technology background

Needham & Company LLC Increases MKS (NASDAQ:MKSI) Price Target to $136.00

NASDAQ:MKSI
Read Needham & Company LLC Increases MKS (NASDAQ:MKSI) Price Target to $136.00
MannKind logo with Medical background

MannKind (NASDAQ:MNKD) Given "Buy" Rating at HC Wainwright

NASDAQ:MNKD
Read MannKind (NASDAQ:MNKD) Given "Buy" Rating at HC Wainwright
Netskope logo with Services background

BTIG Research Initiates Coverage on Netskope (NASDAQ:NTSK)

NASDAQ:NTSK
Read BTIG Research Initiates Coverage on Netskope (NASDAQ:NTSK)
Netskope logo with Services background

Netskope (NASDAQ:NTSK) Now Covered by JPMorgan Chase & Co.

NASDAQ:NTSK
Read Netskope (NASDAQ:NTSK) Now Covered by JPMorgan Chase & Co.
TransMedics Group logo with Medical background

TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial Group

NASDAQ:TMDX
Read TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial Group
Argan logo with Construction background

Argan (NYSE:AGX) Upgraded to Overweight at JPMorgan Chase & Co.

NYSE:AGX
Read Argan (NYSE:AGX) Upgraded to Overweight at JPMorgan Chase & Co.
Carlisle Companies logo with Multi-Sector Conglomerates background

Carlisle Companies (NYSE:CSL) Price Target Cut to $385.00 by Analysts at Robert W. Baird

NYSE:CSL
Read Carlisle Companies (NYSE:CSL) Price Target Cut to $385.00 by Analysts at Robert W. Baird
Eversource Energy logo with Utilities background

Janney Montgomery Scott Reaffirms Neutral Rating for Eversource Energy (NYSE:ES)

NYSE:ES
Read Janney Montgomery Scott Reaffirms Neutral Rating for Eversource Energy (NYSE:ES)
Fastenal logo with Retail/Wholesale background

Fastenal (NASDAQ:FAST) Posts Earnings Results, Misses Expectations By $0.01 EPS

NASDAQ:FAST
Read Fastenal (NASDAQ:FAST) Posts Earnings Results, Misses Expectations By $0.01 EPS
IP Group logo with Financial Services background

IP Group (LON:IPO) Trading 11.4% Higher - Here's Why

LON:IPO
Read IP Group (LON:IPO) Trading 11.4% Higher - Here's Why
hVIVO logo with Medical background

hVIVO (LON:HVO) Trading 13% Higher - Should You Buy?

LON:HVO
Read hVIVO (LON:HVO) Trading 13% Higher - Should You Buy?
Big Yellow Group logo with Real Estate background

Big Yellow Group (LON:BYG) Stock Price Up 17.3% - Still a Buy?

LON:BYG
Read Big Yellow Group (LON:BYG) Stock Price Up 17.3% - Still a Buy?
Mastercard logo with Business Services background

Mastercard Incorporated $MA Stake Lessened by Haverford Financial Services Inc.

NYSE:MA
Read Mastercard Incorporated $MA Stake Lessened by Haverford Financial Services Inc.
Uber Technologies logo with Computer and Technology background

Uber Technologies, Inc. $UBER Shares Bought by NorthRock Partners LLC

NYSE:UBER
Read Uber Technologies, Inc. $UBER Shares Bought by NorthRock Partners LLC
Adobe logo with Computer and Technology background

NorthRock Partners LLC Has $2.15 Million Position in Adobe Inc. $ADBE

NASDAQ:ADBE
Read NorthRock Partners LLC Has $2.15 Million Position in Adobe Inc. $ADBE